Physio-Control price flotation at $14.50 a share
This article was originally published in Clinica
Executive Summary
Physio-Control, the US manufacturer of emergency defibrillators and vital sign assessment devices, has priced its initial public offering at $14.50 a share, close to the lower end of the estimated pricing range in the prospectus. Some 11.7 million shares were sold, 90% by the company's largest shareholder, Bain Capital and affiliated investors.